MAPK1 and ovarian cancer: However, miR-140-3p can also act as a tumor promoter, as demonstrated in ovarian cancer, where it inhibits NK cell recruitment and diminishes cytotoxic effects, thereby promoting ovarian cancer cell growth through the mediation of MAPK1 (Wang et al. 2020a).